Major psychopathologies like schizophrenia are characterized by symptoms including hallucinations, delusions, distorted thinking, and emotional indifference. Symptoms: Positive symptoms: These are signs that occur in addition to everyday experience. Examples include hallucinations (hearing or seeing things that are not there), delusions (false beliefs), and disorganized thinking, such as switching topics often. Negative symptoms: These include symptoms like emotional flatness, lack of desire, and social isolation that signify a loss of normal functioning. Pharmacological therapies: The most often prescribed kind of therapy for schizophrenia is antipsychotic medication. By inhibiting dopamine receptors in the brain, these drugs try to lessen the excessive dopamine activity that is considered to be a factor in the positive symptoms of schizophrenia. Atypical antipsychotics and typical antipsychotics, such chlorpromazine and haloperidol, are the two most popular categories of antipsychotic drugs (such as clozapine, risperidone, and olanzapine) certain hormones/neurotransmitters and receptor varieties: Dopamine is a neurotransmitter that is hypothesized to have a role in schizophrenia's positive symptoms, including delusions and hallucinations. In order to lessen the excessive dopamine activity considered to be a contributing factor to these symptoms, antipsychotic drugs target dopamine receptors in the brain. A neurotransmitter called glutamate is hypothesized to have a role in the unfavorable signs and symptoms of schizophrenia, such as emotional flatness and lack of desire. Some atypical antipsychotic drugs may function by focusing on the brain's glutamate system, according to recent studies. Heritability and/or genetics: Schizophrenia is a complicated condition with several underlying causes, and it is believed that both genetic and environmental variables play a role in its development. According to twin studies, 80% of schizophrenia cases are heritable. The dopamine and glutamate neurotransmitter systems' genes, among others, have been linked to an increased risk of schizophrenia in recent studies. Neuroimaging and other data on the variations and processes of the brain Researchers using structural brain imaging have discovered that those who have schizophrenia have aberrant brain structure, including lower brain volumes and less gray matter in certain parts of the brain, including the prefrontal cortex, temporal lobes, and hippocampus. According to functional neuroimaging studies, people with schizophrenia have aberrant brain activity in particular areas of the brain that are connected to cognitive functions including attention, memory, and emotion. These areas include the prefrontal cortex, temporal lobes, and the hippocampus. Additionally, research has shown that individuals with schizophrenia have aberrant connection across several brain areas, which may be a factor in the disorder's symptoms. Overall, hallucinations, delusions, distorted thinking, and emotional flatness are some of the symptoms of schizophrenia, a complicated condition. The likelihood of getting the illness is considered to be impacted by both hereditary and environmental factors, and research has found many genes that may raise the risk. Antipsychotic medicine, which acts by obstructing dopamine receptors in the brain, is the main therapy for schizophrenia. According to brain imaging studies, people with schizophrenia exhibit aberrant brain structure, activity, and connection between distinct brain areas, all of which may have a role in the symptoms of the condition. 